Home > Insider Trading > Filing (0001231554-11-000003)

Filing Details

Accession Number:: 0001231554-11-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-06-24 15:17:23
Reporting Period:: 2011-06-22

Filing Date:: 2011-06-24
Accepted Time:: 2011-06-24 15:17:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1054833	Coventry Health Care Inc	CVH	Hospital & Medical Service Plans (6324)	522073000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1231554	J John Ruhlmann	6705 Rockledge Drive Suite 900 Bethesda MD 20817	Sr.vp And Corporate Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-06-22	11,250	$32.46	43,352	No	4	M	Direct
Common Stock	Disposition	2011-06-22	11,250	$36.24	32,102	No	4	S	Direct
Common Stock	Acquisiton	2011-06-22	4,000	$20.46	36,102	No	4	M	Direct
Common Stock	Disposition	2011-06-22	4,000	$36.24	32,102	No	4	S	Direct
Common Stock Restricted	Acquisiton	2011-06-22	8,792	$0.00	40,894	No	4	A	Direct
Common Stock Restricted	Disposition	2001-06-22	1,758	$36.11	39,136	No	4	F	Direct
Common Stock Restricted	Disposition	2011-06-22	1,945	$36.26	37,191	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Disposition	2011-06-22	11,250	$0.00	11,250	$32.46
Common Stock	Non-Qualified Stock Option	Disposition	2011-06-22	4,000	$0.00	4,000	$20.46
Common Stock	Non-Qualified Stock Option	Acquisiton	2011-06-22	19,361	$0.00	19,361	$36.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
132,000	2005-06-14	2014-06-14	No	4	M	Direct
128,000	2011-05-26	2020-05-26	No	4	M	Direct
147,361	2012-06-22	2021-06-22	No	4	A	Direct

Footnotes

Includes the following: Table I Non-Derivative Securities comprised of 11,250 shares of common stock held directly, 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
See Footnote 1 for shares held directly and indirectly.
Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
See Footnote 3 for shares held directly and indirectly.
Includes the following: Table I-Non-Derivative Securities comprised of 4,000 shares of common stock held directly, 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
See Footnote 5 for shares held directly and indirectly.
Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 27,947 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
See Footnote 7 for shares held directly and indirectly.
Award of performance-based restricted common stock vesting in equal annual increments over a four-year period.
Includes the following: Table I-Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 36,739 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
See Footnote 10 for shares held directly and indirectly.
Sale of shares back to the Company to pay withholding taxes on release of increment of restricted stock.
Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 34,981 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
See Footnote 13 for shares held directly and indirectly.
Includes the following: Table I Non-Derivative Securities comprised of 4,155 shares of common stock held indirectly by managed account (401(k) Plan), and 33,036 shares of restricted common stock with restrictions lapsed or lapsing over four-year periods, held directly.
See Footnote 15 for shares held directly and indirectly.
Includes the following: Table II Derivative Securities consisting of non-qualified stock options for 122,000 shares of common stock vesting in equal annual increments over three- and four-year periods, held directly and 10,000 performance stock units that will be settled in cash if the award vests.
Includes the following: Table II-Derivative Securities consisting of non-qualified stock options for 118,000 shares of common stock vesting in equal annual increments over three- and four-year periods, held directly and 10,000 performance stock units that will be settled in cash if the award vests.
Includes the following: Table II-Derivative Securities consisting of non-qualified stock options for 137,361 shares of common stock vesting in equal annual increments over three- and four-year periods, held directly and 10,000 performance stock units that will be settled in cash if the award vests.